Oct 30, 2020
I Should Be Confident About Next Tuesday. I’m Petrified.
This news has been received from: thedailybeast.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
Lately, when I talk about this election, I sound like Debbie Downer. With polls showing Biden with a lead in most battleground states, why don’t I have champagne on ice ready to celebrate the blowout a few days away?
Many political analysts, and a fair number of psychiatrists, say folks like me suffer from PTSD triggered by the 2016 election and it prevents us from seeing the blue wave headed our way.Polls, they say, are different this time. Really? It’s a fun indoor MAGA sanctioned sport to punk pollsters, an extension of the fake news. It’s much more satisfying to deliver a November surprise on Election Day.
Our anxiety is due to things we saw all too clearly four years ago and some we’ve only begun to see in the last few months.Trump loves to say the only way he can lose is if Democrats rig the election. The truth, usually the opposite of whatever Trump says, is that the only way Biden can lose is if Trump rigs the election, which is exactly what he’s been doing for some time now. If Trump can’t beat Biden at the ballot box, he’ll work the refs. And if that doesn’t work, he’ll see Biden in court.
News Source: thedailybeast.com
CDC to Vote Tuesday on Who Receives Coronavirus Vaccine First
Joe Raedle/Getty Images
The Centers for Disease Control and Prevention (CDC) is slated to conduct a vote on Tuesday in the hopes of determining who in the United States will be among the first to receive the Covid-19 vaccine.
The CDC’s Advisory Committee for Immunization Practices will hold an “emergency” meeting on Tuesday to determine vaccine “allocation,” according to a CDC document obtained by CNN.
The network said committee members would “discuss who should be in the first group, and clinical considerations for the group.” Drafts suggest that health care workers will be among the first to receive vaccinations.
Tuesday’s vote comes after AstraZeneca’s announcement that it developed a vaccine with an efficacy rate of 70 to 90 percent. Other leading vaccines, developed weeks earlier by Pfizer and BioNTech and Moderna, have shown efficacy rates in excess of 90 percent.
The virus has infected more than 13 million Americans as of Nov. 27, according to data from John Hopkins University, while killing more than 264,000.
Have a tip we should know? [email protected]